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CASE REPORT OPEN
Extradural Motor Cortex Stimulation might improve episodic
and working memory in patients with Parkinson’s disease
Carla Piano1, Marco Ciavarro 2, Francesco Bove 1,3, Daniela Di Giuda4,5, Fabrizio Cocciolillo4, Anna Rita Bentivoglio1,3,
Beatrice Cioni3,6, Tommaso Tufo6✉, Paolo Calabresi1,3 and Antonio Daniele1,3
Electric Extradural Motor Cortex Stimulation (EMCS) is a neurosurgical procedure suggested for treatment of patients with advanced
Parkinson’s disease (PD). We report two PD patients treated by EMCS, who experienced worsening of motor symptoms and
cognition 5 years after surgery, when EMCS batteries became discharged. One month after EMCS restoration, they experienced a
subjective improvement of motor symptoms and cognition. Neuropsychological assessments were carried out before replacement
of batteries (off-EMCS condition) and 6 months afterward (on-EMCS condition). As compared to off-EMCS condition, in on-EMCS
condition both patients showed an improvement on tasks of verbal episodic memory and backward spatial short-term/working
memory task, and a decline on tasks of selective visual attention and forward spatial short-term memory. These findings suggest
that in PD patients EMCS may induce slight beneficial effects on motor symptoms and cognitive processes involved in verbal
episodic memory and in active manipulation of information stored in working memory.
npj Parkinson’s Disease            (2020) 6:26 ; https://doi.org/10.1038/s41531-020-00129-8
INTRODUCTION
Electric chronic Extradural Motor Cortex Stimulation (EMCS) is a
minimally invasive neurosurgical procedure requiring implanta-
tion of extradural electrodes. EMCS has been suggested for
treating patients with Parkinson’s disease (PD) who refuse deep
brain stimulation (DBS) or are not eligible for DBS1,2, due to
contraindications to such more invasive neurosurgical procedure
(age >70 years, dementia, marked brain atrophy, or diffuse chronic
ischemic encephalopathy on brain neuroimaging). Preliminary
observations in PD patients treated by EMCS suggest that
electrical stimulation of the primary motor cortex (PMC) may
modulate neural activity in the basal ganglia (BG), by activating
cortico-BG projections1,3, resulting in slight improvement of
Parkinsonian motor symptoms, especially axial motor symp-
toms4,5. The effects of EMCS on cognitive functioning in patients
with PD remain to be clarified5,6. In PD patients treated by bilateral
EMCS, comparisons between preoperative and postoperative
cognitive performance on neuropsychological tasks did not detect
any significant overall cognitive decline at a 6-month5 and 1-year
postoperative follow-up5,6. One study showed at 3-month post-
operative assessment a significant but transient decline of
performance (increased execution time) only on the Stroop
interference test, a task assessing response inhibition and sensitive
to frontal lobe dysfunction5. By contrast, a statistical trend toward
a post-operative improvement was detected in the same study at
6-month and 12-month postoperative assessments on a task of
verbal episodic long-term memory (LTM), which might have been
influenced by a practice effect5.
In a case of pure akinesia with gait freezing, a variant of
progressive supranuclear palsy (PSP), bilateral EMCS improved
motor symptoms (speech and gait), and cognitive performance on
language (sublexical and lexical-semantic) tasks7.
We report here two PD patients with rigid-akinetic phenotype,
who underwent EMCS, with bilateral implantation over PMC.
Approximately 5 and a half years after surgery, both patients
gradually started to experience a deterioration of motor
symptoms and cognition, noticed also by their relatives. When
visiting patients, we found that EMCS batteries were discharged.
One month after the batteries were replaced, patients experi-
enced a subjective improvement of motor symptoms and
cognition. In order to investigate possible changes in cognitive
performance, apparently related to battery status, patients
underwent an extensive neuropsychological assessment before
(off-EMCS) and 6 months after (on-EMCS) replacement of batteries.
RESULTS
Case reports
Patient 1 is a man with a 11-year history of PD, who started to
show at the age of 59 years Parkinsonian motor symptoms
(rigidity, bradykinesia) and later developed “on–off” fluctuations
and peak-dose dyskinesias. He underwent bilateral EMCS implan-
tation at the age of 70 years, since DBS was contraindicated by
lacunar state in the BG, detected by magnetic resonance imaging.
Patient 2 is a man with a 9-year history of PD, who started to show
at the age of 57 years Parkinsonian motor symptoms (rigidity,
bradykinesia) and later developed postural instability. He under-
went bilateral EMCS implantation at the age of 66 years, since he
refused DBS and showed prominent axial Parkinsonian symptoms
(freezing of gait, postural instability), with poor response to
dopaminergic drugs.
After the EMCS procedure, mild beneficial effects on motor
symptoms (particularly, akinesia and freezing of gait) and a
reduced frequency of falls were seen in both patients. Over time,
motor scores assessed by Unified Parkinson’s Disease Rating Scale
(UPDRS), part III slowly deteriorated in both patients (Table 1), with
an increase of few points (<5) at 60-month postoperative follow-
up. Dopaminergic therapy was reduced over the years following
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EMCS, indicating a reduced need for pharmacological manage-
ment of motor symptoms. These findings suggest that EMCS
might have slight long-standing beneficial effects on PD motor
symptoms, which is a favorable outcome in such progressive
neurodegenerative disorder.
Some months after the 60-month postoperative routine follow-
up, Patient 1 reported a deterioration of motor symptoms
(increased “wearing off” periods, severe rigidity) and cognition
(impaired concentration, memory loss), while Patient 2 complained
about severe akinesia, gait and balance impairment, memory loss,
impaired concentration. Both patients required an unscheduled
neurological assessment. On that occasion, the pulse generator of
the battery hand unexpectedly lost charge in Patient 1 (battery was
at “end of life”), while in Patient 2 generator was switched off, since
battery was out of charge entirely. At that time (66 and 68 months
after EMCS, respectively), patients underwent motor and cognitive
assessments in off-EMCS and showed a deterioration of UPDRS-III
motor scores in off-medication condition (Table 1), as compared to
60-month assessment. After 3 days, batteries were replaced in both
patients. About 1 month after again switching on the EMCS device,
patients reported a subjective improvement of motor symptoms
and cognition via reviews undertaken by telephone. Six months
after switching on the device, patients were reassessed and, as
compared with off-EMCS, motor scores in off-medication condition
improved (Table 1).
As to dosage of anti-parkinsonian drugs (Table 1), in Patient 1
Levodopa-Equivalent Daily Dose (LEDD) was 1257 at baseline and
was reduced to 979 at 60-month follow-up. After deterioration of
motor symptoms was reported by Patient 1 when battery-life was
at the end, an increase of LEDD to 1335 was deemed necessary.
Six months after restarting EMCS, motor symptoms improved and
LEDD was reduced to 1219. In Patient 2, LEDD was 1.250 at
baseline and was reduced to 1.175 at 60-month follow-up.
Although motor symptoms of Patient 2 worsened when battery
was out of charge, LEDD was reduced to 600 at 68-month
assessment, due to episodes of orthostatic hypotension. At 74-
month assessment, LEDD was increased to 850, in an attempt to
improve motor symptoms.
Table 2 reports the results obtained on neuropsychological tests
by both PD patients on three conditions (preoperative baseline,
off-EMCS condition, on-EMCS condition). Comparisons were made
between on-EMCS versus off-EMCS conditions and between the
off-EMCS versus baseline conditions.
At preoperative baseline (about 5 and a half years before
batteries became discharged), both patients showed performance
in the normal range on all neuropsychological tasks, with scores in
lower normal range only on a spatial short-term/working memory
(WM) task (Corsi Block-Tapping Test forward).
As compared to off-EMCS condition, in on-EMCS condition
(about 6 months after replacement of batteries of the EMCS
implant), both patients showed an improved performance on the
backward spatial short-term/WM task (Corsi span backward: +34%
in Patient 1; +29% in Patient 2) and the episodic verbal memory
task (Rey’s Auditory Verbal Learning Test, RAVLT immediate recall:
+26% in Patient 1; +16% in Patient 2; RAVLT delayed recall:
+112% in Patient 1; +13% in Patient 2). Furthermore, in Patient 1
we observed an improved performance on the backward verbal
short-memory task (Digit span backward: +29%) and the
nonverbal abstract reasoning task (Raven’s Progressive Matrices,
RPM ’47: +38%).
By contrast, in on-EMCS condition as compared to off-EMCS
condition, we observed in both patients a decline of performance
on the forward spatial short-memory test (Corsi Spatial forward:
−18% in both patients) and the selective visual attention task
(Multiple Feature Target Cancellation, MFTC), particularly as
regards time of execution in Patient 1 (time of execution:
−350%) and, in both patients to a lesser extent, as regards
accuracy (Patient 1, −18%; Patient 2, −5%). In addition, in Patient
1 a decline was detected on tasks of verbal forward short-term
memory (Digit span forward: −19%) and phonological fluency
(Letter verbal fluency: −18%).
In off-EMCS condition, as compared to preoperative baseline,
we observed in both patients an improved performance on the
Stroop interference test as to time of execution (Patient 1: -22%;
Patient 2: −61% in), on forward Corsi spatial short-memory task
(Patient 1: +35%; Patient 2: +29%), and a very slight improvement
on a forward verbal short-memory task /Digit span (Patient 1: +8%
in; Patient 2: +4%).
By contrast, in off-EMCS condition as compared to preoperative
baseline, neuropsychological assessment showed in both patients
a decline in cognitive performance on tasks of backward verbal
(Digit span in Patient 1: −15%; Patient 2: −26%) and spatial Corsi
short-memory (Patient 1: −20%; Patient 2: −16%), on the
nonverbal abstract reasoning task/RPM 47 (Patient 1: −39%;
Patient 2: −6%) and on the selective visual attention task (MFTC),
as regards both accuracy (−10% in Patient 1; −10% in Patient 2)
Table 1. Motor assessment, Levodopa Equivalent Daily dose, and anti-parkinsonian drugs.













UPDRS off-med 34 36 39 36 21 26 39 35
UPDRS on-med 16 23 23 23 16 25 27 27





















































Motor assessment by means of the Unified Parkinson’s Disease Rating Scale (UPDRS) part III, Levodopa Equivalent Daily dose (LEDD) and pharmacological
treatment with anti-parkinsonian drugs.
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and time of execution (+47% in Patient 1; +67% in Patient 2).
Moreover, only in Patient 1 there was a decline in performance in
off-EMCS condition on two subtests of the episodic verbal memory
test (RAVLT immediate recall: -18%; RAVLT delayed recall: −46%),
on two subtests of constructional apraxia (Copy of drawings: −9%;
Copy of drawings with landmarks: −16%), on the semantic verbal
fluency task (−28%). Furthermore, only in Patient 2 there was a
decline in performance in off-EMCS condition on the phonological
verbal fluency task (Letter verbal Fluency: −39%).
DISCUSSION
In both our PD patients treated by EMCS, there was a subjective
deterioration of motor symptoms and cognitive functioning when
batteries of pulse generator had lost charge (66 and 68 months
after surgery, respectively). One month after battery replacement,
a subjective improvement of motor symptoms and cognition was
reported by both patients. In agreement with such subjective
cognitive improvement associated with EMCS restoration,
6 months after replacement of batteries an objective cognitive
improvement was detected on neuropsychological tasks assessing
backward spatial short-term/WM and episodic verbal memory.
Since patterns of cognitive changes observed across different
assessments in our patients is quite complex, we will mainly focus
on the findings which seem to us more remarkable, by taking into
account not only percent of changes but also changes in
equivalent scores across assessments.
In Patient 1, who showed the most marked cognitive
improvement after battery replacement, as compared to the off-
EMCS condition, we observed in on-EMCS condition a remarkable
improvement of performance on tasks assessing episodic verbal
memory (immediate and delayed recall of RAVLT, which involve
retrieval processes of verbal information stored in LTM) and
nonverbal abstract reasoning (RPM ’47). Furthermore, we
observed a slight improvement on tasks assessing semantic
verbal fluency and response inhibition (Stroop interference test),
and on tasks of short-term/WM requiring active manipulation of
information stored in WM (backward digit and spatial span). In
Patient 2, as compared to the off-EMCS condition, we observed in
on-EMCS condition a slight improvement on a task of short-term/
WM (backward spatial span) and a remarkable improvement of
performance on an episodic verbal memory subtest (immediate
recall of RAVLT). The improvement on a task of episodic verbal
memory (immediate recall subtest of RAVLT test), which cannot be
explained in our two patients by a practice effect, is at least
partially consistent with the results of a previous study carried out
in 9 PD patients treated with EMCS5, showing a statistical trend
towards an improved performance on the same task at 6- and 12-
month postoperative assessments.
Despite some differences in such patterns of improvement in on-
EMCS condition across the two PD patients, we speculate that
restoration of chronic electric stimulation in these subjects may
have induced beneficial effects on activity of neural circuits
involving prefrontal and parietal cortical areas, which play a critical
role in retrieval of information stored in LTM and in processes of
active manipulation of information in WM. The improved perfor-
mance in on-EMCS condition on a task of spatial short-term/WM is
in agreement with experimental study on an animal model of PD, in
which optogenetic stimulation of secondary motor cortex (com-
bined with L-DOPA treatment) resulted in improvement of WM8. It
was hypothesized9 that EMCS might modulate the activity of the
hyperdirect pathway, namely of glutamatergic projections from
subthalamic nucleus, which receives inputs from PMC and
prefrontal cortex10. It could be speculated that modulation of the
hyperdirect pathway might play some role in beneficial effects on
cognitive tasks in which prefrontal cortical areas play a critical role.
By contrast, the deterioration of cognitive performance in on-
EMCS condition (as compared to off-EMCS condition) on other
tests (tasks of selective visual attention and forward spatial short-
memory in both patients, tasks of verbal forward short-term
memory and phonological fluency in Patient 1) seems to us of
difficult interpretation. Possibly, restoration of chronic electric
stimulation in these subjects may have detrimental effects mainly
on activity of neural circuits which play a critical role in cognitive
processes underlying selective visual attention task and storage of
visuo-spatial information in short-term memory.
The improvement of cognitive performance in off-EMCS
condition as compared to preoperative baseline (5 and 1/2 years
earlier) in both patients on some cognitive tasks (forward spatial
short-memory task, reduced execution time in the Stroop
Interference test) is of interest, but of not easy interpretation.
We speculate that, despite being accidentally interrupted for
some time before off-EMCS assessment, EMCS might have
induced, over a period of more than 5 years, phenomena of
neural plasticity in cortical-subcortical circuits underlying cogni-
tive processes, such as response inhibition. This latter hypothesis,
however, is not easy to reconcile with the observation of an
increased execution time on the Stroop Interference test in PD
patients treated by EMCS5, at least in early phases (namely, at 3-
month postoperative assessment).
In experimental rodent models of PD, high frequency stimula-
tion of glutamatergic corticostriatal inputs may induce opposite
forms of synaptic plasticity, such as long-term potentiation (LTP)
and long-term depression (LTD). Both corticostriatal LTP and LTD
depend on functional state of postsynaptic neurons, integrity or
denervation of nigral dopaminergic inputs, and concomitant
administration of L-DOPA11,12. Moreover, in PD experimental
models motor and cognitive functions can be differentially
affected by distinct changes in corticostriatal synaptic plasticity
induced by high-frequency stimulation13–15. Thus, such complex
synaptic changes may account for beneficial and detrimental
effects observed in our patients following EMCS.
The deterioration of cognitive performance in off-EMCS
condition as compared to preoperative baseline (about 5 years
before) on other cognitive tasks (mainly on tasks assessing verbal
and spatial short-memory, nonverbal abstract reasoning, selective
visual attention) could possibly be due to detrimental effects of
disease progression on some cognitive processes, despite
phenomena of neural plasticity induced by EMCS.
EMCS does require at least 1 month to induce, through
phenomena of neural plasticity, beneficial effects in patients with
various neurological disorders (chronic pain, stroke, PD)5,16–19,
Accordingly, beneficial effects of EMCS were subjectively reported
by our patients about 1 month after restarting of EMCS and
persisted up to 6 months. Thus, although a placebo effect could
be hypothesized to explain beneficial effects observed after
restarting of EMCS, such hypothesis seems unlikely. It remains to
be clarified whether in our PD patients an improvement on some
cognitive tasks might partially reflect beneficial effects of EMCS on
motor symptoms.
A limitation of the present report is the lack of assessments in a
sham condition or in a blinded condition. However, a sham
assessment is difficult in patients treated by EMCS, since EMCS
requires at least 1 month to induce clinical effects, as mentioned
above. Moreover, since our patients were not aware that batteries
had lost charge, assessments in OFF-EMCS could be considered
close to a single-blinded evaluation.
Further studies on a larger sample size and with long-term
follow-up (which should foresee a matched control group and
metabolic/functional imaging) are certainly needed in order to
confirm the present preliminary findings observed in our two PD
patients.
The main findings observed in the two patients reported here,
assessed before and after restoration of EMCS, suggest that in PD
patients EMCS might induce beneficial effects on motor symp-
toms and cognitive processes involved in verbal episodic LTM (as
C. Piano et al.
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already suggested by a previous study5) and in active manipula-
tion of information stored in WM. Since EMCS induced beneficial
effects on linguistic functions in a patient affected by PSP7, it is
possible that EMCS might induce beneficial effects on different
cognitive processes in distinct movement disorders.
METHODS
Study design
In both patients, a quadripolar electrode strip (Resume, Medtronic) was
placed extradurally over the PMC of both cerebral hemispheres (Fig.1),
using neuronavigation, intraoperative neurophysiology, and the phase
reversal technique to identify the central sulcus20. The stimulation was
continuously delivered through the two most distant contacts of the
electrode paddle under a bipolar setting (parameters: 3-3.5 V, 120 μs,
80 Hz).
Both patients underwent a preoperative cognitive assessment (1 week
before electrode implantation) and periodic postoperative follow-up
cognitive assessment (at 6, 12, 36, 60 months post-surgery, not reported
here), by means of an extensive neuropsychological test battery5,
assessing various cognitive domains (short-term/working memory, LTM,
attention, praxic abilities, language, abstract reasoning, and executive/
frontal cognitive functions). The neuropsychological battery included the
Mini-Mental State Examination (MMSE), tasks of spatial (forward and
backward Corsi Block-Tapping Test) and verbal (forward and backward
Digit Span) short-term/WM, tasks of verbal episodic LTM (RAVLT) with
parallel versions to minimize practice effects, tasks of selective visual
attention (MFTC), nonverbal abstract reasoning (RPM ‘47), phonological
and semantic verbal fluency, response inhibition (Stroop interference
test), and constructional praxis (Copy of drawings and Copy of drawings
with landmarks).
Moreover, additional postoperative neuropsychological assessments
(reported in detail here) were carried out before (off-EMCS condition,
when the battery status was very low) and 6 months after the substitution
of batteries of pulse generators (on-EMCS condition). All neuropsycholo-
gical assessments were carried out in on-medication conditions. The ethics
committee of the Catholic University of Sacred Hearth approved the study
(#400-A763), and patients provide written informed consent.
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